This session presents quantitative MRI studies examining brain alterations associated with HIV, cannabis use, antiretroviral exposure, and COVID-19. Using spectroscopy, diffusion imaging, and microstructural metrics, the talks highlight metabolic, inflammatory, and white matter changes, advancing neuroimaging biomarkers for infection-related, substance-associated, and post-viral neurological effects.